Kabra Drugs Ltd

Kabra Drugs Ltd Q3 FY26: Net Profit of ₹256.65 Lakhs 📊

• Revenue from operations for Q3 FY26: ₹3,042.00 lakhs

• Total income for Q3 FY26: ₹3,060.43 lakhs

• Net profit after tax for Q3 FY26: ₹256.65 lakhs (vs. loss of ₹53.69 lakhs in same quarter last year)

• Nine-month net profit after tax: ₹390.34 lakhs (vs. loss of ₹147.85 lakhs in prior year period)

• Earnings per share (EPS) for Q3 FY26: ₹1.08 (basic and diluted)

• EPS for the nine-month period: ₹1.65